PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\', \'German Center for Infection Research, Partner site Bonn-Cologne, Cologne, Germany.\', \'Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.\', \'Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and Department of Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. florian.klein@uk-koeln.de.\', \'German Center for Infection Research, Partner site Bonn-Cologne, Cologne, Germany. florian.klein@uk-koeln.de.\', \'Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. florian.klein@uk-koeln.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41591-021-01676-0
?:doi
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 35046572
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
is ?:relation_isRelatedTo_publication of
?:title
  • mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all